Driehaus Small Cap Growth Investor holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
Driehaus Small Cap Growth Fund Investor Class DVSMX
- NAV / 1-Day Return 29.69 / −1.98 %
- Total Assets 1.4B
-
Adj. Expense Ratio
0.930%
- Expense Ratio 0.910%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 10,000
- Status Limited
- TTM Yield 0.18%
- Turnover 152%
USD | NAV as of Jun 11, 2026 | 1-Day Return as of Jun 11, 2026, 5:18 AM GMT+0
Morningstar’s Analysis DVSMX
Will DVSMX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the DVSMX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of DVSMX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Planet Labs PBC Class A | 2.35 | 32M | Industrials |
Bloom Energy Corp Class A | 2.24 | 31M | Industrials |
Lumentum Holdings Inc | 2.01 | 28M | Technology |
Credo Technology Group Holding Ltd | 1.87 | 26M | Technology |
Praxis Precision Medicines Inc Ordinary Shares | 1.85 | 25M | Healthcare |
Crinetics Pharmaceuticals Inc | 1.60 | 22M | Healthcare |
Spyre Therapeutics Inc | 1.58 | 22M | Healthcare |
Curtiss-Wright Corp | 1.56 | 22M | Industrials |
Xenon Pharmaceuticals Inc | 1.43 | 20M | Healthcare |
Coherent Corp | 1.36 | 19M | Technology |
United States